Aclaris Therapeutics, Inc.
ACRS· Nasdaq
ACRSAclaris Therapeutics, Inc.
Filed May 9, 2017 · 10-Q · 39 days after period end · 0001558370-17-004000
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Net Income | -$12.56M | -$13.04M | -$2.62M | -$1.03M |
| EPS Diluted | -$0.48 | -$0.65 | -$1.61 | -$0.95 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aclaris Therapeutics, Inc. · CIK 1557746 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end
